These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 109597

  • 1. Impaired parathyroid response to induced hypocalcemia in thalassemia major.
    Gertner JM, Broadus AE, Anast CS, Grey M, Pearson H, Genel M.
    J Pediatr; 1979 Aug; 95(2):210-3. PubMed ID: 109597
    [Abstract] [Full Text] [Related]

  • 2. Acute parathyroid response in EDTA-induced hypocalcemia and its application to a functional test of the parathyroid gland in cattle.
    Saeki T, Hayashi M.
    Natl Inst Anim Health Q (Tokyo); 1977 Aug; 17(2):67-72. PubMed ID: 407479
    [No Abstract] [Full Text] [Related]

  • 3. Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
    Cossu P, Toccafondi C, Vardeu F, Sanna G, Frau F, Lobrano R, Cornacchia G, Nucaro A, Bertolino F, Loi A, De Virgiliis S, Cao A.
    Eur J Pediatr; 1981 Nov; 137(3):267-71. PubMed ID: 7318837
    [Abstract] [Full Text] [Related]

  • 4. The spectrum of parathyroid function in thalassaemia subjects with transfusional iron overload.
    Brezis M, Shalev O, Leibel B, Dagan I, Ben-Ishay D.
    Miner Electrolyte Metab; 1982 Dec; 8(6):307-13. PubMed ID: 6300636
    [No Abstract] [Full Text] [Related]

  • 5. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP, Kumar S, Choudhury P, Talukdar B, Puri RK.
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [Abstract] [Full Text] [Related]

  • 6. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982 Jun; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 7. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia.
    Chern JP, Lin KH.
    J Pediatr Hematol Oncol; 2002 May; 24(4):291-3. PubMed ID: 11972098
    [Abstract] [Full Text] [Related]

  • 8. [Study of the pathogenic mechanism of hypocalcemia in primary hypomagnesemia. Demonstration of a blockage of the mechanism of release of parathyroid hormone].
    David L, Chapuis MC, Collombel C, Racle B, Racle P, François R.
    Arch Fr Pediatr; 1975 Nov; 32(9):803-13. PubMed ID: 1217953
    [Abstract] [Full Text] [Related]

  • 9. Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
    De Virgiliis S, Cossu P, Sanna G, Frau F, Loi E, Lobrano R, Nucaro A, Toccafondi C, Cornacchia G, Loi A, Cao A.
    Acta Haematol; 1982 Nov; 67(1):49-56. PubMed ID: 6800202
    [Abstract] [Full Text] [Related]

  • 10. Response to long-term deferoxamine therapy in thalassemia.
    Cohen A, Martin M, Schwartz E.
    J Pediatr; 1981 Nov; 99(5):689-94. PubMed ID: 7299539
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 12. Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients.
    De Sanctis V, Vullo C, Bagni B, Chiccoli L.
    Acta Haematol; 1992 Apr; 88(2-3):105-8. PubMed ID: 1466190
    [Abstract] [Full Text] [Related]

  • 13. Effect of rate of calcium reduction and a hypocalcemic clamp on parathyroid hormone secretion: a study in dogs.
    Estepa JC, Aguilera-Tejero E, Almaden Y, Rodriguez M, Felsenfeld AJ.
    Kidney Int; 1999 May; 55(5):1724-33. PubMed ID: 10231434
    [Abstract] [Full Text] [Related]

  • 14. Acute parathyroid hormone response: sensitivity, relationship to hypocalcemia, and rapidity.
    Blum JW, Fischer JA, Schwoerer D, Hunziker W, Binswanger U.
    Endocrinology; 1974 Sep; 95(3):753-9. PubMed ID: 4850418
    [No Abstract] [Full Text] [Related]

  • 15. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
    Girot R, Triadou P, Bories D, Jeannel F, Thevenin M, Rymer JC.
    Nouv Rev Fr Hematol (1978); 1982 Sep; 24(5):281-7. PubMed ID: 7167380
    [Abstract] [Full Text] [Related]

  • 16. Urinary phosphate and cyclic AMP excretion following citrate-induced hypocalcemic stimulation of the neonatal parathyroid glands.
    Brown DR, Donovan EF, Tsang RC, Bobik CM, Chen IW, Johnson JR.
    J Pediatr; 1978 Nov; 93(5):842-6. PubMed ID: 213548
    [Abstract] [Full Text] [Related]

  • 17. Urinary iron excretion induced by intravenous infusion of deferoxamine in beta-thalassemia homozygous patients.
    Boturao-Neto E, Marcopito LF, Zago MA.
    Braz J Med Biol Res; 2002 Nov; 35(11):1319-28. PubMed ID: 12426631
    [Abstract] [Full Text] [Related]

  • 18. The iron status of Italian subjects with beta-thalassemia trait.
    Fargion S, Taddei MT, Cappellini MD, Piperno A, Fiorelli G.
    Acta Haematol; 1982 Nov; 68(2):109-14. PubMed ID: 6812365
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.
    Hussain MA, Green N, Flynn DM, Hussein S, Hoffbrand AV.
    Lancet; 1976 Dec 11; 2(7998):1278-80. PubMed ID: 63749
    [Abstract] [Full Text] [Related]

  • 20. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
    Moayedi B, Gharagozloo M, Esmaeil N, Maracy MR, Hoorfar H, Jalaeikar M.
    Eur J Haematol; 2013 Mar 11; 90(3):202-9. PubMed ID: 23278124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.